New clip device tames leaky heart valve in japanese patients

NCT ID NCT07509658

First seen Apr 19, 2026 · Last updated May 24, 2026 · Updated 4 times

Summary

This study checks how safe and effective the TriClip system is for people in Japan with a leaky heart valve (tricuspid regurgitation). About 250 patients will get the device and be followed for 30 days. The goal is to see if the leak improves to moderate or less and if the device stays attached properly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • National Cerebral & Cardiovascular Center Hospital

    RECRUITING

    Suita, Osaka, 564-8565, Japan

    Contact

Conditions

Explore the condition pages connected to this study.